Caprock Group’s Dr. Reddy's Laboratories RDY Stock Holding History

Caprock Group’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$470K	Sell	32,404 -11,683	-26%	-$158K	0.01%	871
2026 Q1	$611K	Buy	44,087 +3,738	+9%	+$52K	0.01%	684
2025 Q4	$567K	Buy	40,349 +3,563	+10%	+$50K	0.01%	775
2025 Q3	$522K	Buy	+36,786	New	+$529K	0.01%	795
2025 Q1	$482K	Sell	36,511 -22,052	-38%	-$304K	0.01%	731
2024 Q4	$925K	Sell	58,563 -18,427	-24%	-$277K	0.03%	442
2024 Q3	$1.22M	Buy	76,990 +11,590	+18%	+$187K	0.04%	345
2024 Q2	$997K	Buy	+65,400	New	+$937K	0.04%	371

Other funds holding RDY

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

AIM

Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Caprock Group's RDY Position: Q2 2026 in Review

Caprock Group reduced its Dr. Reddy's Laboratories (RDY) stake by 26% in Q2 2026, selling an estimated $158K and leaving 32,404 shares worth $470K. The position accounts for 0.01% of the portfolio, ranked #871.

Caprock Group first reported a position in RDY in Q2 2024 and has held it in 8 quarters since. The position peaked at $1.22M in Q3 2024. 238 funds tracked by Wall St. Rank hold RDY as of Q2 2026.

Caprock Group held 32,404 shares of Dr. Reddy's Laboratories worth $470K as of Q2 2026.
Caprock Group sold 11,683 Dr. Reddy's Laboratories shares in Q2 2026, an estimated $158K.
Dr. Reddy's Laboratories made up 0.01% of Caprock Group's portfolio in Q2 2026, its #871 holding.
Caprock Group first reported a position in Dr. Reddy's Laboratories in Q2 2024 and has held it in 8 quarters since.
Caprock Group's Dr. Reddy's Laboratories position peaked at $1.22M in Q3 2024.
238 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2026.

Based on Caprock Group's 13F filing for Q2 2026, filed 27 Jul 2026.